Pet Therapeutics Market, Global Outlook and Forecast 2022-2028

April 2022 | 66 pages | ID: P19203F1448AEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Pet Therapeutics in Global, including the following market information:

Global Pet Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Pet Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Infectious Diseases Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Pet Therapeutics include Elanco, Boehringer Ingelheim GmbH, Ceva Sante Animale, Dechra Pharmaceuticals, Eli Lilly and Company, Merck, Vetoquinol and Zoetis, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pet Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Pet Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Pet Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Infectious Diseases
• Dermatological Diseases
• Orthopedic Diseases
• Behavioral Disorders
• Others

Global Pet Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Pet Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Dogs
• Cats
• Other

Global Pet Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Pet Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Pet Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Pet Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Elanco
• Boehringer Ingelheim GmbH
• Ceva Sante Animale
• Dechra Pharmaceuticals
• Eli Lilly and Company
• Merck
• Vetoquinol
• Zoetis

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Pet Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Pet Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PET THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Pet Therapeutics Market Size: 2021 VS 2028
2.2 Global Pet Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Pet Therapeutics Players in Global Market
3.2 Top Global Pet Therapeutics Companies Ranked by Revenue
3.3 Global Pet Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Pet Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Pet Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pet Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Pet Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Pet Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Pet Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Infectious Diseases
  4.1.3 Dermatological Diseases
  4.1.4 Orthopedic Diseases
  4.1.5 Behavioral Disorders
  4.1.6 Others
4.2 By Type - Global Pet Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Pet Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Pet Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Pet Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Pet Therapeutics Market Size, 2021 & 2028
  5.1.2 Dogs
  5.1.3 Cats
  5.1.4 Other
5.2 By Application - Global Pet Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Pet Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Pet Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Pet Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Pet Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Pet Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Pet Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Pet Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Pet Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Pet Therapeutics Revenue, 2017-2028
  6.3.2 US Pet Therapeutics Market Size, 2017-2028
  6.3.3 Canada Pet Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Pet Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Pet Therapeutics Revenue, 2017-2028
  6.4.2 Germany Pet Therapeutics Market Size, 2017-2028
  6.4.3 France Pet Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Pet Therapeutics Market Size, 2017-2028
  6.4.5 Italy Pet Therapeutics Market Size, 2017-2028
  6.4.6 Russia Pet Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Pet Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Pet Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Pet Therapeutics Revenue, 2017-2028
  6.5.2 China Pet Therapeutics Market Size, 2017-2028
  6.5.3 Japan Pet Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Pet Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Pet Therapeutics Market Size, 2017-2028
  6.5.6 India Pet Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Pet Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Pet Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Pet Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Pet Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Pet Therapeutics Market Size, 2017-2028
  6.7.3 Israel Pet Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Pet Therapeutics Market Size, 2017-2028
  6.7.5 UAE Pet Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Elanco
  7.1.1 Elanco Corporate Summary
  7.1.2 Elanco Business Overview
  7.1.3 Elanco Pet Therapeutics Major Product Offerings
  7.1.4 Elanco Pet Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 Elanco Key News
7.2 Boehringer Ingelheim GmbH
  7.2.1 Boehringer Ingelheim GmbH Corporate Summary
  7.2.2 Boehringer Ingelheim GmbH Business Overview
  7.2.3 Boehringer Ingelheim GmbH Pet Therapeutics Major Product Offerings
  7.2.4 Boehringer Ingelheim GmbH Pet Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Boehringer Ingelheim GmbH Key News
7.3 Ceva Sante Animale
  7.3.1 Ceva Sante Animale Corporate Summary
  7.3.2 Ceva Sante Animale Business Overview
  7.3.3 Ceva Sante Animale Pet Therapeutics Major Product Offerings
  7.3.4 Ceva Sante Animale Pet Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Ceva Sante Animale Key News
7.4 Dechra Pharmaceuticals
  7.4.1 Dechra Pharmaceuticals Corporate Summary
  7.4.2 Dechra Pharmaceuticals Business Overview
  7.4.3 Dechra Pharmaceuticals Pet Therapeutics Major Product Offerings
  7.4.4 Dechra Pharmaceuticals Pet Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Dechra Pharmaceuticals Key News
7.5 Eli Lilly and Company
  7.5.1 Eli Lilly and Company Corporate Summary
  7.5.2 Eli Lilly and Company Business Overview
  7.5.3 Eli Lilly and Company Pet Therapeutics Major Product Offerings
  7.5.4 Eli Lilly and Company Pet Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Eli Lilly and Company Key News
7.6 Merck
  7.6.1 Merck Corporate Summary
  7.6.2 Merck Business Overview
  7.6.3 Merck Pet Therapeutics Major Product Offerings
  7.6.4 Merck Pet Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 Merck Key News
7.7 Vetoquinol
  7.7.1 Vetoquinol Corporate Summary
  7.7.2 Vetoquinol Business Overview
  7.7.3 Vetoquinol Pet Therapeutics Major Product Offerings
  7.7.4 Vetoquinol Pet Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 Vetoquinol Key News
7.8 Zoetis
  7.8.1 Zoetis Corporate Summary
  7.8.2 Zoetis Business Overview
  7.8.3 Zoetis Pet Therapeutics Major Product Offerings
  7.8.4 Zoetis Pet Therapeutics Revenue in Global Market (2017-2022)
  7.8.5 Zoetis Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Pet Therapeutics Market Opportunities & Trends in Global Market
Table 2. Pet Therapeutics Market Drivers in Global Market
Table 3. Pet Therapeutics Market Restraints in Global Market
Table 4. Key Players of Pet Therapeutics in Global Market
Table 5. Top Pet Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Pet Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Pet Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Pet Therapeutics Product Type
Table 9. List of Global Tier 1 Pet Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pet Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Pet Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Pet Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Pet Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Pet Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Pet Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Pet Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Pet Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Pet Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Pet Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Pet Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Pet Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Pet Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Pet Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Pet Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Pet Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Pet Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Pet Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Pet Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Pet Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Elanco Corporate Summary
Table 31. Elanco Pet Therapeutics Product Offerings
Table 32. Elanco Pet Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Boehringer Ingelheim GmbH Corporate Summary
Table 34. Boehringer Ingelheim GmbH Pet Therapeutics Product Offerings
Table 35. Boehringer Ingelheim GmbH Pet Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Ceva Sante Animale Corporate Summary
Table 37. Ceva Sante Animale Pet Therapeutics Product Offerings
Table 38. Ceva Sante Animale Pet Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Dechra Pharmaceuticals Corporate Summary
Table 40. Dechra Pharmaceuticals Pet Therapeutics Product Offerings
Table 41. Dechra Pharmaceuticals Pet Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Eli Lilly and Company Corporate Summary
Table 43. Eli Lilly and Company Pet Therapeutics Product Offerings
Table 44. Eli Lilly and Company Pet Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Merck Corporate Summary
Table 46. Merck Pet Therapeutics Product Offerings
Table 47. Merck Pet Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Vetoquinol Corporate Summary
Table 49. Vetoquinol Pet Therapeutics Product Offerings
Table 50. Vetoquinol Pet Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Zoetis Corporate Summary
Table 52. Zoetis Pet Therapeutics Product Offerings
Table 53. Zoetis Pet Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Pet Therapeutics Segment by Type in 2021
Figure 2. Pet Therapeutics Segment by Application in 2021
Figure 3. Global Pet Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Pet Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Pet Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pet Therapeutics Revenue in 2021
Figure 8. By Type - Global Pet Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Pet Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Pet Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Pet Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Pet Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Pet Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Pet Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Pet Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Pet Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Pet Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Pet Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Pet Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Pet Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Pet Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Pet Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Pet Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Pet Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Pet Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Pet Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Pet Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Pet Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Pet Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Pet Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Pet Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Pet Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Pet Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Pet Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Pet Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Pet Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Elanco Pet Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Boehringer Ingelheim GmbH Pet Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Ceva Sante Animale Pet Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Dechra Pharmaceuticals Pet Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Eli Lilly and Company Pet Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Merck Pet Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Vetoquinol Pet Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Zoetis Pet Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)